Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Nonalcoholic steatohepatitis (NASH) is a condition which can progress to cirrhosis and hepatocellular carcinoma. Markers for NASH diagnosis are still lacking. We performed a comprehensive lipidomic analysis on human liver biopsies including normal liver, nonalcoholic fatty liver and NASH. Random forests-based machine learning approach allowed characterizing a signature of 32 lipids discriminating NASH with 100% sensitivity and specificity. Furthermore, we validated this signature in an independent group of NASH patients. Then, metabolism dysregulations were investigated in both patients and murine models. Alterations of elongase and desaturase activities were observed along the fatty acid synthesis pathway. The decreased activity of the desaturase FADS1 appeared as a bottleneck, leading upstream to an accumulation of fatty acids and downstream to a deficiency of long-chain fatty acids resulting to impaired phospholipid synthesis. In NASH, mass spectrometry imaging on tissue section revealed the spreading into the hepatic parenchyma of selectively accumulated fatty acids. Such lipids constituted a highly toxic mixture to human hepatocytes. In conclusion, this study characterized a specific and sensitive lipid signature of NASH and positioned FADS1 as a significant player in accumulating toxic lipids during NASH progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These data were confirmed by Chiappini et al.,98 who showed a significant reduction in PC, PE and SM in MASH.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 4×
“defined by the presence of steatosis, ballooning of hepatocytes, Mallory’s bodies and lobular inflammation with infiltrated macrophages and leukocytes on liver histology 8,9 .”
InfluentialMembrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 432
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.031 · Cited by 332
Physiological and pathological roles of lipogenesis
Jeon, Y. G., Kim, Y. Y., Lee, G., & Kim, J. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00786-y · Cited by 243
Wei, W., Wong, C. C., Jia, Z., Liu, W., Liu, C., Ji, F., Pan, Y., Wang, F., Wang, G., Zhao, L., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01418-7 · Cited by 248
Metabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 221
Farrell, G. C., Haczeyni, F., & Chitturi, S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-8684-7_3 · Cited by 178
Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 162
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Syed‐Abdul, M. M. (2023) · Metabolites · doi:10.3390/metabo14010012 · Cited by 179
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 156
Lipidomics in non-alcoholic fatty liver disease
Kartsoli, S., Kostara, C. E., Tsimihodimos, V., Bairaktari, E. T., & Christodoulou, D. K. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i8.436 · Cited by 163
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Boland, M. L., Oró, D., Tølbøl, K. S., Thrane, S. T., Nielsen, J. C., Cohen, T. S., Tabor, D. E., Fernandes, F., Tovchigrechko, A., Veidal, S. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4904 · Cited by 129
Ghosh, S., Zhao, X., Alim, M., Brudno, M., & Bhat, M. (2024) · Gut · doi:10.1136/gutjnl-2023-331740 · Cited by 128
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
Kuchay, M. S., Choudhary, N. S., & Ramos‐Molina, B. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00951.2024 · Cited by 115
The metabolic basis of nonalcoholic steatohepatitis
Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 103
Martinou, E., Pericleous, M., Stefanova, I., Kaur, V., & Angelidi, A. M. (2022) · Diagnostics · doi:10.3390/diagnostics12020407 · Cited by 104
Nonalcoholic fatty liver disease stratification by liver lipidomics
Vvedenskaya, O., Rose, T. D., Knittelfelder, O. L., Palladini, A., Wodke, J. A. H., Schuhmann, K., Ackerman, J. M., Wang, Y., Has, C., Brosch, M., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100104 · Cited by 89
Martins, C., Dreij, K., & Costa, P. M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234718 · Cited by 84
Membrane lipids and transporter function
Stieger, B., Steiger, J., & Locher, K. P. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166079 · Cited by 88
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Beyoğlu, D., & Idle, J. R. (2020) · Metabolites · doi:10.3390/metabo10020050 · Cited by 81
Drummer, C., Saaoud, F., Jhala, N. C., Cueto, R., Sun, Y., Xu, K., Shao, Y., Lu, Y., Shen, H., Yang, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113883 · Cited by 83
Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kim, K. H., & Lee, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00485 · Cited by 83
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Cao, L.-Q., Xie, Y., Fleishman, J. S., Liu, X., & Chen, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217061 · Cited by 84
The hepatic lipidome: From basic science to clinical translation
ten Hove, M., Pater, L. V., Storm, G., Weiskirchen, S., Weiskirchen, R., Lammers, T., & Bansal, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.027 · Cited by 79
Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity
Ščupáková, K., Soons, Z. I. T. A., Ertaylan, G., Pierzchalski, K., Eijkel, G. B., Ellis, S. R., Greve, J. W. M., Driessen, A. L. C., Verheij, J., de Kok, T. M. C. M., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05215 · Cited by 74
Stuani, L., Riols, F., Millard, P., Sabatier, M., Batut, A., Saland, E., Viars, F., Tonini, L., Zaghdoudi, S., Linares, L. K., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113325 · Cited by 75
Self-citationLee, S. M., Pusec, C. M., Norris, G. H., Jesus, A. D., Díaz‐Ruiz, A., Muratalla, J. T., Sarmento‐Cabral, A., Guzman, G., Layden, B. T., & Córdoba‐Chacón, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.003 · Cited by 77
Musso, G., Saba, F., Cassader, M., & Gambino, R. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101238 · Cited by 74
The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 70
Petriello, M. C., Brandon, J. A., Hoffman, J., Wang, C., Tripathi, H., Abdel-Latif, A., Ye, X., Li, X., Yang, L., Lee, E., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx275 · Cited by 67
The role of hepatic lipid composition in obesity‐related metabolic disease
Willis, S. A., Bawden, S., Malaikah, S., Sargeant, J. A., Stensel, D. J., Aithal, G. P., & King, J. A. (2021) · Liver International · doi:10.1111/liv.15059 · Cited by 69
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Zhu, Q., Li, H., Ao, Z., Xu, H., luo, J., Kaurich, C., Yang, R., Zhu, P., Chen, S., Tang, L., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01540-4 · Cited by 62
Wong, A. M., Ding, X., Wong, A. M. G., Xu, M., Zhang, L., Leung, H. H. W., Chan, A. W. H., Song, Q. X., Kwong, J., Chan, L. K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.015 · Cited by 63
Davinelli, S., Intrieri, M., Corbi, G., & Scapagnini, G. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1724871 · Cited by 59
Montandon, S. A., Somm, E., Loizides‐Mangold, U., Vito, C. D., Dibner, C., & Jornayvaz, F. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-53346-4 · Cited by 59
Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
Thiele, M. S., Suvitaival, T., Trôst, K., Kim, M. G., de Zawadzki, A., Kjærgaard, M., Rasmussen, D. N., Lindvig, K. P., Israelsen, M. E., Detlefsen, S., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.023 · Cited by 62
Mocciaro, G., Allison, M. E., Jenkins, B., Azzu, V., Huang‐Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Davies, S. E., Frontini, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101728 · Cited by 58
Caro-Gómez, E., Sierra, J. A., Escobar, J. S., Álvarez, R., Naranjo, M., Medina, S., Velásquez-Mejía, E. P., Tabares-Guevara, J. H., Jaramillo, J. C., León-Varela, Y. M., et al. (2019) · Nutrients · doi:10.3390/nu11030497 · Cited by 58
Saraswathi, V., Kumar, N., Ai, W., Gopal, T., Bhatt, S., Harris, E. N., Talmon, G. A., & Desouza, C. V. (2022) · Biomolecules · doi:10.3390/biom12060739 · Cited by 55
Azzu, V., Vacca, M., Kamzolas, I., Hall, Z., Leslie, J., Carobbio, S., Virtue, S., Davies, S. E., Lukasik, A., Dale, M., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101210 · Cited by 52
“Dysregulation of DNL and cholesterol synthesis in liver metabolism is a feature of NASH [11,12] and fibrogenesis [13].”
BackgroundRadhakrishnan, S., Yeung, S. F., Ke, J., Antunes, M. M., & Pellizzon, M. (2021) · Current Developments in Nutrition · doi:10.1093/cdn/nzab138 · Cited by 56
Qian, M., Hu, H., Yao, Y., Zhao, D., Wang, S., Pan, C., Duan, X., Gao, Y., Liu, J., Zhang, Y., et al. (2019) · Liver International · doi:10.1111/liv.14316 · Cited by 49
A human liver chimeric mouse model for non-alcoholic fatty liver disease
Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B., Ochsner, S. A., Barzi, M., Legras, X., Yang, D., Borowiak, M., Dean, A. M., York, R. B., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100281 · Cited by 49
Swine Inflammation and Necrosis Syndrome (SINS)
Reiner, G., Kuehling, J., Loewenstein, F., Lechner, M., & Becker, S. (2021) · Animals · doi:10.3390/ani11061670 · Cited by 51
Mouse models of non‐alcoholic steatohepatitis: A reflection on recent literature
Haczeyni, F., Yeh, M. M., Ioannou, G. N., Leclercq, I. A., Goldin, R. D., Dan, Y. Y., Yu, J. Q., Teoh, N., & Farrell, G. C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14122 · Cited by 48
Parra‐Robert, M., Casals, E., Massana, N., Zeng, M., Perramón, M., Fernández‐Varo, G., Morales‐Ruiz, M., Puntes, V., Jiménez, W., & Casals, G. (2019) · Biomolecules · doi:10.3390/biom9090425 · Cited by 49
Clusters of Ultrasound Scattering Parameters for the Classification of Steatotic and Normal Livers
Baek, J., Poul, S. S., Basavarajappa, L., Reddy, S., Tai, H., Hoyt, K., & Parker, K. J. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.06.010 · Cited by 47
Liu, H., Chen, T., Xie, X., Wang, X., Luo, Y., Xu, N., Sa, Z., Zhang, M., Chen, Z., Hu, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03379 · Cited by 46
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
Ramai, D., Tai, W., Rivera, M. L., Facciorusso, A., Tartaglia, N., Pacilli, M., Ambrosi, A., Cotsoglou, C., & Sacco, R. (2021) · Biomedicines · doi:10.3390/biomedicines9020184 · Cited by 45
Benhammou, J. N., Ko, A., Alvarez, M., Kaikkonen, M. U., Rankin, C. R., Garske, K. M., Padua, D. M., Bhagat, Y. V., Kamińska, D., Kärjä, V. J., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1413 · Cited by 44
You, M., Zhang, S., Shen, Y., Zhao, X., Chen, L., Liu, J., & Ma, N. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102352 · Cited by 42
Perakakis, N., Stefanakis, K., Feigh, M., Veidal, S. S., & Mantzoros, C. S. (2021) · Liver International · doi:10.1111/liv.14888 · Cited by 42
Restoration of Lipid Homeostasis between TG and PE by the LXRα-ATGL/EPT1 Axis Ameliorates Obesity
Chen, Y., Jiang, H., Zhan, Z., Lu, J., Gu, T., Yu, P., Liang, W., Zhang, X., Liu, S., Bi, H., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-023-05613-6 · Cited by 42
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Mann, J. P., Pietzner, M., Wittemans, L. B., Rolfe, E. D. L., Kerrison, N. D., Imamura, F., Forouhi, N. G., Fauman, E., Allison, M. E., Griffin, J. L., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa162 · Cited by 38
Tawfeek, G. A.-E., & Kasem, H. A. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101837 · Cited by 39
Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?
Grunhut, J., Wang, W., Aykut, B., Gakhal, I., Torres-Hernandez, A., & Miller, G. (2018) · EMJ Hepatology · doi:10.33590/emjhepatol/10312252 · Cited by 40
Scattering Signatures of Normal versus Abnormal Livers with Support Vector Machine Classification
Baek, J., Poul, S. S., Swanson, T. A., Tuthill, T. A., & Parker, K. J. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.08.009 · Cited by 37
Quantitative imaging of lipid droplets in single cells
Gupta, A., Dorlhiac, G., & Streets, A. (2018) · The Analyst · doi:10.1039/c8an01525b · Cited by 37
Su, R. C., Lad, A. C., Breidenbach, J. D., Blomquist, T. M., Gunning, W. T., Dube, P. R., Kleinhenz, A. L., Malhotra, D. K., Haller, S. T., & Kennedy, D. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225604 · Cited by 47
Castañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., Rodríguez‐Tomàs, E., Fernández‐Arroyo, S., Herrero, P., Delpino-Rius, A., Canela-Canela, N., Menéndez, J. A., Camps, J., et al. (2021) · Biomolecules · doi:10.3390/biom11030473 · Cited by 36
Bourganou, M. V., Chondrogianni, M. E., Kyrou, I., Flessa, C., Chatzigeorgiou, A., Oikonomou, E. K., Lambadiari, V., Randeva, H. S., & Kassi, E. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041589 · Cited by 37
Papandreou, C., Bulló, M., Tinahones, F. J., Martínez‐González, M. Á., Corella, D., Fragkiadakis, G. A., López‐Miranda, J., Estruch, R., Fitó, M., & Salas‐Salvadó, J. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0213-3 · Cited by 35
Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma
Teo, J. M. N., Chen, Z., Chen, W., Tan, R. J. Y., Cao, Q., Chu, Y., Ma, D., Chen, L., Yu, H., Lam, K.-H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20241442 · Cited by 37
AbdulHameed, M. D. M., Pannala, V. R., & Wallqvist, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01007 · Cited by 33
Desterke, C., & Chiappini, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225594 · Cited by 33
Self-citationRole of hepatic lipid species in the progression of nonalcoholic fatty liver disease
Deng, K., Huang, X., Lei, F., Zhang, X., Zhang, P., She, Z., Cai, J., Ji, Y., & Li, H. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00123.2022 · Cited by 32
Xu, G., Quan, S., Schell, J. R., Gao, Y., Varmazyad, M., Sreenivas, P., Cruz, D., Jiang, H., Pan, M., Han, X., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj5942 · Cited by 33
Männistö, V., Kamińska, D., Kärjä, V. J., Tiainen, M., de Mello, V. D., Hanhineva, K., Soininen, P., Ala‐Korpela, M., & Pihlajamäki, J. (2019) · Liver International · doi:10.1111/liv.14174 · Cited by 29
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rios, R. S., Zheng, K. I., & Zheng, M.-H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001888 · Cited by 29
Martínez‐Montoro, J. I., Núñez‐Sánchez, M. Á., Martínez‐Sánchez, M. A., Román, A. B., Fernández-Ruiz, V. E., Ferrer‐Gómez, M., Śledziński, T., Frutos, M. D., Fernández‐García, J. C., Mika, A., et al. (2023) · Obesity · doi:10.1002/oby.23711 · Cited by 29
Kim, K. E., Shin, H. J., Ju, Y., Jung, Y., An, H. S., Lee, S. J., Jeong, E. A., Lee, J., Hwang, G., & Roh, G. S. (2023) · Nutrients · doi:10.3390/nu15214574 · Cited by 33
Haberl, E. M., Pohl, R., Rein‐Fischboeck, L., Höring, M., Krautbauer, S., Liebisch, G., & Buechler, C. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01425-1 · Cited by 30
The lipidome in nonalcoholic fatty liver disease: actionable targets
Pirola, C. J., & Sookoian, S. C. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100073 · Cited by 30
Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
Albhaisi, S. A. M., & Sanyal, A. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665987 · Cited by 29
Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver
Zhou, Y., Peng, H., Xu, H., Li, J., Golovko, M. Y., Cheng, H., Lynch, E. C., Liu, L., McCauley, N., Kennedy, L. L., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0344-4 · Cited by 29
Artificial intelligence applied to omics data in liver diseases: Enhancing clinical predictions
Baciu, C., Xu, C., Alim, M., Prayitno, K., & Bhat, M. (2022) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2022.1050439 · Cited by 27
Vouilloz, A., Bourgeois, T., Diedisheim, M., Pilot, T., Jalil, A., Guern, N. L., Bergas, V., Rohmer, N., Castelli, F. A., Leleu, D., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156051 · Cited by 31
Simões, I. C. M., Janikiewicz, J., Bauer, J., Karkucińska‐Więckowska, A., Kalinowski, P., Dobrzyń, A., Wolski, A., Pronicki, M., Zieniewicz, K., Dobrzyń, P., et al. (2019) · Nutrients · doi:10.3390/nu11122871 · Cited by 29
Cardiometabolic Syndrome: An Update on Available Mouse Models
Aravani, D., Kassi, E. N., Chatzigeorgiou, A., & Vakrou, S. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721388 · Cited by 30
Wang, Z., Zheng, K. I., Wang, X., Qiao, J., Li, Y., Zhang, L. R., Zheng, M., & Wu, J. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.05.008 · Cited by 27
Iwata, A., Maruyama, J., Natsuki, S., Nishiyama, A., Tamura, T., Tanaka, M., Shichino, S., Seki, T., Komai, T., Okamura, T., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06357-5 · Cited by 25
Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
Benhammou, J. N., Lin, J., Hussain, S. K., & El-Kabany, M. M. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2020.16 · Cited by 26
Fridén, M., Rosqvist, F., Ahlström, H. K., Niessen, H. G., Schultheis, C., Hockings, P. D., Hulthe, J., Gummesson, A., Wanders, A., Rorsman, F., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814951 · Cited by 29
Núñez‐Sánchez, M. Á., Martínez‐Sánchez, M. A., Martínez‐Montoro, J. I., Román, A. B., García, E. M., Fernández-Ruiz, V. E., Ferrer‐Gómez, M., Martínez, C. M., Śledziński, T., Frutos, M. D., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae028 · Cited by 27
Improving lipid mapping in Genome Scale Metabolic Networks using ontologies
Poupin, N., Vinson, F., Moreau, A., Batut, A., Chazalviel, M., Colsch, B., Fouillen, L., Guez, S., Khoury, S., Dalloux-Chioccioli, J., et al. (2020) · Metabolomics · doi:10.1007/s11306-020-01663-5 · Cited by 25
Self-citationDefining NASH from a Multi-Omics Systems Biology Perspective
Niu, L., Sulek, K., Vasilopoulou, C. G., Santos, A., Albrechtsen, N. J. W., Rasmussen, S., Meier, F., & Mann, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204673 · Cited by 24
Anari, M., & Montgomery, M. K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115621 · Cited by 24
Bai, Y., Nan, Y., Wu, T., Zhu, A., Xie, X., Sun, Y., Deng, Y., Dou, Z., Hu, X., Zhou, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202400493 · Cited by 27
Karimi‐Sales, E., Kalan, A. E., & Alipour, M. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.196 · Cited by 24
Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis
Gao, B., Wu, T.-C., Lang, S., Jiang, L., Duan, Y., Fouts, D. E., Zhang, X., Tu, X.-M., & Schnabl, B. (2022) · Metabolites · doi:10.3390/metabo12010041 · Cited by 26
Dong, Y., Lu, H., Li, Q., Qi, X., Li, Y., Zhang, Z., Chen, J., & Ren, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116644 · Cited by 24
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
Gîlcă-Blanariu, G.-E., Budur, D. S., Mitrică, D., Gologan, E., Timofte, O., Bălan, G. G., OLTEANU, V.-A., & Ștefănescu, G. (2023) · Metabolites · doi:10.3390/metabo13111115 · Cited by 25
The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
Östlund, C., Hernández‐Ono, A., & Shin, J. (2020) · Biology · doi:10.3390/biology9100338 · Cited by 23
Ringseis, R., Geßner, D. K., Loewenstein, F., Kuehling, J., Becker, S., Willems, H., Lechner, M., Eder, K., & Reiner, G. (2021) · Animals · doi:10.3390/ani11030772 · Cited by 20
Chen, L., Liu, Y., Mu, H., Li, H., Liu, S., Zhu, M., Bu, Y., & Wu, B. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120403 · Cited by 20
Wang, M., Liu, Y., Zhao, T., Xiao, F., Yang, X., & Lu, B. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100516 · Cited by 21
Mazi, T. A., Borkowski, K., Newman, J. W. I., Fiehn, O., Bowlus, C. L., Sarkar, S., Matsukuma, K. E., Ali, M. R., Kieffer, D. A., Wan, Y. Y., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.06.024 · Cited by 19
Metadata
- Authors
- Chiappini, F., Coilly, A., Kadar, H., Gual, P., Tran, A., Desterke, C., Samuel, D., Duclos-Vallée, J.-C., Touboul, D., Bertrand-Michel, J., Brunelle, A., Guettier, C., & Le Naour, F.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Corresponding author
- Chiappini, Franck
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-04-24
- Volume
- 7
- Issue
- 1
- Pages
- 46658-46658
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5402394
- OpenAlex
- W2609371482
- Cited by
- 246
- References
- 71
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 35 · 2023: 37 · 2022: 27 · 2021: 36 · 2020: 28 · 2019: 19 · 2018: 14 · 2017: 2
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS, ANR-10, ANR-10-LABX, ANR-10-LABX-0033, ANR-11-INBS-0010)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale (SPF20111223621)
- Centre National de la Recherche Scientifique (ANR-11-INBS-0010)
- Centre Hospitalier Universitaire de Nice
- Université Paris-Sud
- Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- nonalcoholic steatohepatitis, lipidomics, lipid signatures, FADS1, fatty acid desaturase, fatty acid synthesis, fatty acid accumulation, phospholipid synthesis, hepatocyte cytotoxicity, non-alcoholic fatty liver disease, liver biopsy, mass spectrometry imaging, metabolic dysfunction, NASH diagnosis
- MeSH terms
- Fatty Acid Elongases, Delta-5 Fatty Acid Desaturase, Acetyltransferases, Adult, Animals, Cells, Cultured, Fatty Acids, Female, Carcinoma, Hepatocellular, Humans, Lipids, Liver Cirrhosis, Liver Neoplasms, Male, Mice, Inbred C57BL, Middle Aged, Disease Progression, Hepatocytes, Fatty Acid Desaturases, Lipid Metabolism, Metabolomics, Hep G2 Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.